 REHOVOT, Israel, Sept. 9, 2019 PRNewswire -- CollPlant CLGN the Company, a regenerative medicine company, announced it has closed on a total of 5.5 million in convertible loans. A group of U.S. accredited investors with deep experience in the 3D printing industry purchased 3.5 million of the convertible loans, and the Companys largest shareholder, Ami Sagi, purchased 2.0 million of the convertible loans, through a non-brokered private placement. An additional 1.0 million investment will be made by Ami Sagi following the execution of a license andor a co-development agreement between CollPlant and a strategic business partner, if such were to occur. 